Medivolve Inc MEDVF

Healthcare Copper

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

OTCPK:MEDVF - Post by User

Medivolve Inc

<< Previous

Bullboard Posts

Next >>

Post by deepoil0808on Nov 16, 2021 11:56am

109 Views

Post# 34132162

Testing NOT sustainable: Pandemic ends Jan 4th 2022 (Pfizer)

Per Pfizer the pandemic officially ends on January 4, 2022.

Biden also lost his appeal, no forced vaccines or testing. Starting in Texas. 19 other states sued and similar results pending.

Little to no pivot to telehealth market.

Unable to pay debts in November 2021: $ 411,000 was paid with shares

Paltry amount in bank: $ 900,000 as of October 31, 2021

Bloated accounts payable: $ 20,500,000

Overhang of shares: 180 million shares that need to be sold

Dilution: 1 for 15 reverse stock split is being proposed

Next quarter forecast: Sales slowdown + loss from operations.

My personal opinion

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions